DeVENT [COVID-19] [UPH]

  • Research type

    Research Study

  • Full title

    Decision support system to evaluate VENTilation in ARDS (DeVENT)

  • IRAS ID

    266521

  • Contact name

    Brijesh Patel

  • Contact email

    brijesh.patel@imperial.ac.uk

  • ISRCTN Number

    ISRCTN51550701

  • Clinicaltrials.gov Identifier

    NCT04115709

  • Duration of Study in the UK

    1 years, 5 months, 31 days

  • Research summary

    Patients with Acute Respiratory Distress Syndrome (ARDS) residing in the intensive care unit (ICU) often require support for their breathing from a mechanical ventilator to provide adequate gas exchange, and although it is life-saving in this setting, it is also known to contribute to the morbidity and mortality in the condition. \n\nMechanical ventilation delivers a volume and pressure of gas for each breath and can vary oxygen levels. Selecting the correct oxygen, pressure and volume levels is important, as incorrect levels can harm the patient, and result in an increased time connected to the ventilator.\nRecently, a system has been developed (the Beacon Caresystem) which advises the healthcare practitioner by the bedside as to how to best set the ventilator. This system is based on mathematics which describes the patients disease and may therefore provide ventilator settings which better suit the individual. The purpose of this study is to compare mechanical ventilation in ARDS patients following advice from the Beacon Caresystem to that of standard care to investigate whether the use of the system results in improved ventilation in all severities and phases of ARDS and thus reducing morbidity in ARDS. We plan to recruit 110 patients (50 in the UK and 30 in each of the other 2 sites). The study also aims to examine the biological and physiological factors that determine the worsening of ARDS and the processes involved in recovery from ARDS with the aim to develop new therapies to help detect the condition and improve recovery.\n\nWe will utilise all raw data will be collected from the Beacon Caresystem to physiologically characterise the progression and resolution phases of ARDS. Additionally blood and Urine samples will be taken from healthy volunteers (100 in total)as a control comparison group for the biological analyses carried out in the DeVENT study. [COVID-19 amendment - 20/05/2020]

  • REC name

    London - South East Research Ethics Committee

  • REC reference

    19/LO/1606

  • Date of REC Opinion

    15 Jan 2020

  • REC opinion

    Further Information Favourable Opinion